| Net income | -17.68M |
| Depreciation and amortization | |
| Stock-based compensation expense | |
| Stock-based compensation expense-non-employee | |
| Allowance for doubtful accounts | |
| Deferred income taxes | |
| Other non-cash items | |
| Accounts receivable | 7.12M |
| Inventory | -8.7M |
| Prepaid expenses and other current assets | 2.84M |
| Accounts payable and accrued expenses | -4.48M |
| Deferred revenue | 4.5M |
| Net cash used in operating activities | |
| Purchase of property, plant and equipment | -359K |
| Purchase of marketable securities | |
| Proceeds from the maturity of marketable securities | |
| Change in restricted cash | 4K |
| Purchase of intangible assets | |
| Purchase of minority investment | |
| Change in other assets | -28K |
| Net cash used in investing activities | |
| Proceeds from follow-on public offering, net of costs | |
| Proceeds from exercise of employee stock options and ESPP | 0 |
| Net cash provided by financing activities | |
| Effect of exchange rate changes on cash and cash equivalents | -298K |
| Net increase (decrease) in cash and cash equivalents | -14.07M |
| Cash and cash equivalents at beginning of period | 39.33M |
| Cash and cash equivalents at end of period | 25.26M |
| Non-cash contingent consideration in connection with acquisitions | |
| Cash paid for income taxes | |
| Non-cash issuance of common stock | |